Thomas Lycan, MD
Wake Forest Baptist Comprehensive Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Thomas Lycan, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:41 UTC. Open this list on ClinicalTrials.gov
- N/ANCT05984680 · COPD Care Pathway Among Patients With CancerWake Forest University Health Sciences · completed · Chronic Obstructive Pulmonary Disease, Lung Cancer, Head and Neck Cancer · principal investigator
- Ph2NCT05696782 · Quick Start Durvalumab Following Chemoradiation for Stage III Nonsmall Cell Lung CancerWake Forest University Health Sciences · recruiting · Nonsmall Cell Lung Cancer Stage III, Unresectable Non-Small Cell Lung Carcinoma, Nonsmall Cell Lung Cancer, Stage II · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:41 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Cancer Prevention and Control Research ProgramP30CA012197 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Ruben A. Mesa · fiscal years 2000 to 2026Named on NCT05984680, NCT05696782
- CTSA K12 Program at Wake ForestK12TR004931 · NCATS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Nicholette D. Allred · fiscal years 2024 to 2026Named on NCT05984680
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in non-small cell lung cancer.